We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
Out of stock
This item is currently unavailable
Gone for 57 days. Could come back at any time — we're watching for you.
Out of stock 57 days
The 2025-2030 World Outlook for CRISPR and Cas Genes
One email. No newsletter. No nudges.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
No price data yet
Price history will appear here once data is collected from Amazon.
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
No price data available for histogram
Description
This study covers the world outlook for CRISPR and Cas genes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of CRISPR and Cas genes as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Addgene, Agilent Technologies, Applied StemCell, AstraZeneca, Beam Therapeutics, Calyxt, Caribou Biosciences, Cellecta, Cellectis, Cibus, CRISPR Therapeutics, Danaher Corporation, Dharmacon, Editas Medicine, Egenesis, F. Hoffmann - La Roche, Ltd., GenScript, Hera BioLabs, Horizon Discovery Group, Inscripta, Inc., Integrated DNA Technologies, Intellia Therapeutics, Lonza Group, Mammoth Biosciences, Merck KGaA, Mirus Bio, New England Biolabs, OriGene Technologies, Plantedit, Recombinetics, Inc., Sigma - Aldrich Co., LLC, Synthego, Takara Bio, Thermo Fisher Scientific, Transposagen Biopharmaceuticals, and Vertex Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).
Product Specifications
- Format
- paperback
- ASIN
- B0CZ2JSPYV
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 03 March 2024
- Listed Since
- 17 April 2024
Similar Products You Might Like
99% match
The 2025-2030 World Outlook for CRISPR Technologies
Price unavailable
99% match
The 2025-2030 World Outlook for CRISPR Genome Editing and Genome Engineering
Price unavailable
99% match
The 2023-2028 World Outlook for CRISPR and Cas Genes
£795.00
25 Aug 2026
98% match
The 2025-2030 World Outlook for CRISPR-CAS9 Mice Models
Price unavailable
98% match
The 2023-2028 World Outlook for CRISPR Genome Editing and Genome Engineering
£795.00
21 Aug 2026
98% match
The 2023 Report on CRISPR and Cas Genes: World Market Segmentation by City
£795.00
11 Aug 2026
97% match
The 2023 Report on CRISPR Genome Editing and Genome Engineering: World Market Segmentation by City
£795.00
25 Aug 2026
97% match
The 2023-2028 World Outlook for Plant Breeding and CRISPR Plants
£795.00
25 Aug 2026
97% match
The 2023 Report on CRISPR-CAS9 Mice Models: World Market Segmentation by City
£795.00
25 Aug 2026
97% match
Edición Génica: CRISPR-Cas9 en Medicina: Edición Génica para células animales y humanas
£170.96
28 Aug 2026
96% match
The 2023 Report on Plant Breeding and CRISPR Plants: World Market Segmentation by City
£795.00
25 Aug 2026
96% match
Global Regulatory Outlook for CRISPRized Plants (Genome Modified Plants and Microbes in Food and Agriculture)
Elsevier
£166.99
28 Aug 2026
96% match
Applications of CRISPR-Cas9 in Translational Research - Springer
Springer
Price unavailable
96% match
Engineering Disease Resistance in Plants using CRISPR-Cas
CRC Press
£131.18
20 Sep 2026
96% match
Gene Editing by CRISPR-Cas
CRC Press
£107.20
17 Sep 2026
95% match
CRISPR/Cas9 Plant Genome Engineering - Academic Press Guide
Elsevier
£141.99
03 Oct 2026
95% match
Gene Editing in Plants: CRISPR-Cas and Its Applications
Springer
£160.86
23 Sep 2026
95% match
CRISPR-Cas9 as a Revolutionary Gene Editing Tool: Genome Engineering, Advances and Applications in Agriculture
CRC Press
£140.00
23 Sep 2026
95% match
CRISPR: Methods and Protocols: 1311 (Methods in Molecular Biology, 1311)
Humana
£100.53
03 Oct 2026
95% match
CRISPR Technologies - Advances in Genome Editing, Applications, and Ethical Implications (Genetics)
IntechOpen
£119.00
22 Sep 2026
95% match
CRISPR: Methods and Protocols: 1311 (Methods in Molecular Biology, 1311)
Humana
£117.14
26 Sep 2026
95% match
CRISPR-Cas9 und methanotrophe Bakterien: Verbesserung der Leistung von methylotrophen Bakterien durch CRISPR/Cas9 Gene Editing System für den biologischen Abbau von Kohlenwasserstoffen
£68.00
06 Sep 2026
95% match
The 2016-2021 Outlook for Epigenetic Technologies in Greater China
£595.00
27 Aug 2026
95% match